United Capital Financial Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-5,671
| Closed | -$473K | – | 1248 |
|
2021
Q3 | $473K | Buy |
5,671
+141
| +3% | +$11.8K | ﹤0.01% | 872 |
|
2021
Q2 | $525K | Hold |
5,530
| – | – | ﹤0.01% | 846 |
|
2021
Q1 | $920K | Buy |
5,530
+1,300
| +31% | +$216K | 0.01% | 693 |
|
2020
Q4 | $415K | Hold |
4,230
| – | – | ﹤0.01% | 894 |
|
2020
Q3 | $144K | Hold |
4,230
| – | – | ﹤0.01% | 1091 |
|
2020
Q2 | $240K | Hold |
4,230
| – | – | ﹤0.01% | 1044 |
|
2020
Q1 | $248K | Buy |
4,230
+355
| +9% | +$20.8K | ﹤0.01% | 1012 |
|
2019
Q4 | $306K | Buy |
3,875
+57
| +1% | +$4.5K | ﹤0.01% | 1120 |
|
2019
Q3 | $382K | Buy |
+3,818
| New | +$382K | ﹤0.01% | 1016 |
|